What is the proper structured format for a cardiac diagnosis note?

Structured Format for Cardiac Diagnosis Notes

A cardiac diagnosis note should follow a standardized seven-component structure: Administrative Information, Patient Demographics, Study Referral Data, History and Risk Factors, Study Description, Study Findings with Interpretation, and Other Reporting Parameters. 1

1. Administrative Information and Laboratory Identification

• Document the laboratory name, site location, facility type, complete address, phone number, and accreditation entity with current status 1
• Include unique study identifiers or accession numbers to facilitate retrieval regardless of storage medium 1

2. Patient Demographics and Billing Information

• Record the patient's full name at time of test, any prior names used for previous tests, medical record number, date of birth, gender, and race 1
• Include insurance or payer information required for billing 1
• Provide sufficient redundancy in identifiers to correct errors and allow comparison of data over time and across providers 1

3. Study Referral Data

• Document the clinical situation, specific clinical questions being asked, study indication, and referring provider identification with National Physician Identifier 1
• Include date and time of order, study priority (routine, urgent, stat), and special handling instructions such as callback numbers 1

4. History and Risk Factors

Current Symptoms

• Document cardiac symptoms including dyspnea, orthopnea, paroxysmal nocturnal dyspnea, weight changes, swelling, fatigue, and chest pain with onset and duration for each 2
• Record chest pain characteristics: substernal location, provocation by exertion or emotional distress, and relief by rest or nitroglycerin 1
• Assign NYHA functional class (I-IV) for heart failure patients based on activity limitation 1, 2
• Assign Canadian Cardiovascular Angina Class (0-4) for angina patients based on symptom severity with activity 1, 2

Cardiovascular History

• Document all previous myocardial infarctions with dates of first and most recent episodes 2
• Record history of coronary artery disease including prior CABG with date, prior PCI with date, angiographically documented stenosis ≥50%, positive stress tests, or angina pectoris 1, 2
• Document heart failure history including physician documentation of dyspnea, fluid retention, low cardiac output, or physical findings 2
• Record valvular heart disease with documented moderate or severe stenosis or regurgitation, indicating which valves are involved 2
• Document complete arrhythmia history including atrial fibrillation, atrial flutter, frequent PVCs, ventricular tachycardia, and any prior ablation procedures 2

Risk Factors

• Document hypertension defined by history of diagnosis, blood pressure ≥140/90 mm Hg, or current antihypertensive therapy 2
• Record most recent blood pressure including both systolic and diastolic readings 2
• Document dyslipidemia based on physician diagnosis or National Cholesterol Education Program criteria 2
• Record most recent lipid values including LDL and HDL measurements 2
• Document diabetes mellitus regardless of duration, including fasting blood sugar >126 mg/dL 2
• Record detailed family history of premature cardiovascular disease (first-degree male <55 years or female <65 years) 2

Previous Testing

• Document diagnostic imaging tests within 24 months including stress SPECT MPI, stress TTE, TTE, TEE, CACS, CCTA, CMR, invasive coronary angiography, or ECG-only stress test with dates 1, 2
• Record previous test results including coronary artery stenosis ≥50%, stenosis <50%, myocardial ischemia, scar/MI, cardiac mass/thrombus/vegetation, significant LV systolic dysfunction, pericardial disease, valvular heart disease, or congenital heart disease 1, 2

Medications

• Compile complete medication list including antiplatelet agents, β-blockers, lipid-lowering drugs, ACE inhibitors/ARBs with drug name, dose, and frequency 2
• Evaluate each medication for risk-benefit ratio, possible interactions and adverse effects, adherence to treatment, and unmet needs 2

5. Study Description

• Describe the imaging modality and technical specifications of image acquisition in detail using generic rather than proprietary terminology 1
• Document the name, dose, and method of administration of contrast agents or medications if used 1
• For radiation-based modalities, include dose-reduction strategies employed and estimated dose or exposure received 1
• For stress testing, indicate the method of inducing stress (exercise and/or pharmacological) and the specific stress protocol used 1
• Note overall study quality with mention of any limitations due to patient-related, equipment-related, or other circumstances 1

6. Study Findings, Interpretation, and Conclusions

Quantitative and Qualitative Assessments

• Group all quantitative measures, qualitative assessments, and calculated data by anatomic structure in logical sequence (e.g., left ventricular size, shape, wall thickness, systolic and diastolic function appear in adjacent items) 1
• Reference measurements to norms for body size, gender, and age, reporting with corresponding Z-scores when relevant 1
• Use the 17-segment model as the consensus standard for left ventricular description by tomographic imaging to document ischemia, scarring, or wall motion abnormalities 1

Interpretation and Conclusions

• Include clearly identified fields for interpretation of findings 1
• Compare to prior studies if available 1
• Provide conclusions and impressions 1
• Explicitly answer the original question for which the study was performed 1
• Include any recommendations as a result of the study 1
• Document physiological and hemodynamic changes observed during the study, whether spontaneous or in response to stress or other interventions 1

7. Other Reporting Parameters

• Include names and identifiers of all individuals involved in the study: technicians, trainees, nurses, physician assistants, and the interpreting physician with credentials 1
• Document the date and time of the examination and the date and time of the finalized report 1
• Add an attestation clause if any portion of the examination or report was performed by a trainee 1
• Document transfer of care when results or critical findings are reported in person or via phone to the referring physician, including date, time, and name of receiving individual 1
• Include date, time, and name of responsible individual for any amendments to a finalized report 1

Common Pitfalls to Avoid

• Do not use proprietary terminology when generic descriptions are available 1
• Do not omit comparison to prior studies when available, as this provides critical context 1
• Do not fail to explicitly answer the clinical question that prompted the study 1
• Do not report measurements without appropriate reference to normative values adjusted for body size, gender, and age 1
• Do not use non-standardized anatomic descriptions when consensus models (such as the 17-segment model for left ventricle) exist 1